The medical mechanism against type I allergies is to block the release or production of chemical mediators from mast cells or to block the H1-receptor signaling. We previously reported that the anti-allergic action of the dry powder from Bidens pilosa L. var. radiata SCHERFF treated with the enzyme cellulosine (eMMBP) was dependent on the inhibition of histamine release from mast cells. Here, we investigate that the effect of fractions in eMMBP on the histamine-induced contraction in guinea pig ileum and on the release of histamine in rat peritoneal mast cells. The histamine-induced contraction in guinea pig ileum is dose-dependently inhibited by ketotifen, an antagonist of H1-receptor. Fractions contained caffeic acid, caffeoylquinic acid and fractions contained flavonoids such as hyperin and isoquercitrin in eMMBP inhibit histamine release from mast cells, but only flavonoids such as hyperin, isoquercitrin and rutin suppress the histamineinduced contraction in guinea pig ileum. Moreover, the histamine-induced contraction was not affected by caffeic acid, however, such contraction was significantly inhibited by rutin. These results suggest that the primary antagonists of H1-receptor are different from the components in eMMBP that inhibit histamine release, and that these components participate in the anti-allergic activity of eMMBP.
Introduction
The prevalence of allergic disease including asthma, atopic dermatitis and allergic rhinitis has increased in Japan as well as in other developed countries during the last two decades (Tanaka et al., 2006) . Although allergic diseases have not yet been recognized as life-style related diseases, dietary changes were recently proposed to be associated with this increase Correspondence to: Dr. Masako Horiuchi, Department of Clinical Chemistry, Hoshi University, 2-4-41 Ebara, Shinagawa-ku, Tokyo 142-8501, Japan Phone & FAX: +81-3-5498-5856 e-mail: horiuchi@hoshi.ac.jp (Yamamoto et al., 2007) . Indeed, some nutrients in foods or drink possess anti-allergic or allergic activities.
Bidens pilosa L. (Kosendangusa in Japanese compositae) is a herbaceous plant widely distributed in Africa, America, China, and Japan. It is used in traditional medicines for inflammation and the treatment of various diseases, including hepatitis and diabetes. Bidens pilosa L. var. radiata SCHERFF (Tachiawayukisendangusa in Japanese) is originally native to tropical America. It was introduced to Miyako Island, in Japan's Okinawa prefecture, where residents harvested and steamed the aerial parts. The dried powder was used as an ingredient in tea such as Kampo-tea ® for traditional drugs. We previously reported that a variety of Bidens pilosa L. var. radiata SCHERFF, specifically, Musashino Research Institute for Immunity, Miyako Island, Bidens pilosa (MMBP), inhibits histamine release from mast cells as well as vascular permeability (Horiuchi and Seyama, 2006) . MMBP is a variety cultivated without agricultural chemicals on Miyako Island in Japan's Okinawa Prefecture; and it was derived from Bidens pilosa. var. pilosa. Six caffeoylquinic acids (neochlorogenic acid, chlorogenic acid, 4-O-caffeoylquinic acid, 3,4-di-O-caffeoylquinic acid, 3,5-di-O-caffeoylquinic acid and 4,5-di-O-caffeoylquinic acid) and 7 flavonoids (rutin, quercetin, quercetin derivative, hyperin, isoquercitrin, centaurein and jacein) have been isolated from MMBP (Kusano et al., 2003) . We recently found that MMBP and MMBP treated with the enzyme cellulosine (eMMBP) showed anti-allergic activity. A type I allergic reaction is induced by chemical mediators such as histamine, serotonin and prostaglandin. Histamine released from mast cells is regarded as one of the chemical mediators that trigger an allergic reaction. Therefore, the inhibition of the release of histamine could inhibit the emergence of allergic symptoms. MMBP has been found to inhibit histamine release from mast cells (Horiuchi and Seyama, 2006) , and eMMBP is more effective than MMBP in producing this inhibition because certain components of MMBP (caffeic acid and flavonoids) are increased in eMMBP due to the enzyme treatment. However, the biologically active components contained in eMMBP were not clarified.
The medical mechanism against type I allergies is to block the release or production of chemical mediators from mast cells or of antagonists of chemical mediators. MMBP and eMMBP inhibit the release of chemical mediators from mast cells. However, other mechanisms of MMBP and eMMBP remain unclear. Thus, the present study was undertaken to determine the anti-allergic compounds isolated from an extract of eMMBP and the mechanism behind the effect of eMMBP on histamine-induced contraction of guinea pig ileum.
Methods

Animals
Male Wistar rats (200 g) and male Hartley guinea pigs (490-670 g) were purchased from Sankyo Japan SLC, Inc. (Shizuoka, Japan). The animals were maintained in an air-conditioned room controlled for temperature (24 ± 1°C) and humidity (55 ± 5%). The rats were given standard laboratory food (MF; Oriental Yeast Co., Ltd., Tokyo, Japan) and water ad libitum. The guinea pigs were given standard laboratory food (ORC-4; Oriental Yeast) and water ad libitum in an air-controlled environment (room temperature 24 ± 1°C, room humidity 55 ± 5%). Technology, Japan).
Plant material
Plant material was prepared as described previously Seyama, 2006, 2008) . MMBP was harvested on Miyako Island, Okinawa Prefecture, Japan, and the aerial parts were harvested and steamed. The dried powder used in the present study was provided by the Musashino Research Institute for Immunity. The dried powder of eMMBP was obtained from MMBP treated with the enzyme cellulosine (HBI, Inc., Hyogo, Japan) and was also provided by the Musashino Research Institute for Immunity. Each fraction in eMMBP was dissolved in PBS (Phosphate-buffered saline) or KHS (Krebs-Henseleit solution) for comparison with other fractions.
Chemicals
The following chemicals were used in the present experiments: ketotifen fumarate, histamine dihydrochloride, ketotifen and Compound 48/80; all were obtained from Sigma Chemical Co. (St. Louis, MO, USA).
Extraction and isolation
Caffeic acid, caffeoylquinic acid derivatives and flavonoids in eMMBP were separated by high-performance liquid chromatography (HPLC) following the protocol described in our previous report (Kusano et al., 2003) . Briefly, eMMBP dissolved in water was extracted by refluxing in water. After the residue was obtained, it was filtered through a cellulose acetate membrane (0.45 µm; Advantec, Tokyo, Japan), and the filtrate was used as a sample, which was then subjected to chromatography using a DIAION HP20 (Mitsubishi Chemical, Tokyo, Japan).
The fraction was eluted with 50% MeOH.
A 5-µl portion of the filtrate was injected into an HPLC system consisting of a BENSEL 5 C18 column oven (preparative column size, 10.0 × 250 mm; analytical column size, 4.6 × 50 mm), two LC-10AD pumps, an SIL-10AXL autoinjector, and a Fasterertls UV-VIS (A254) photodiode array.
The filtrate was eluted with increasing amounts of MeOH in H2O (20% MeOH or less, 30%, 40%, 50% and 100%), and the fractions were collected for examination and identified as A1, A2, A3, A4 and A5. Fraction A4 was further purified by the same column chromatography procedure and its main peaks were collected as A4-1, A4-2, A4-3 and A4-4. The temperature was maintained at room temperature. The mobile phase consisted of MeOH/0.02 M KH2PO4: 30/70 for preparation, and MeOH/0.1% (NH4)2CO3 (to pH 3.0 by trifluoroacetic acid): 30/70 for analysis.
The flow rate was 1 ml/ min.
Compound 48/80 or DNP-ascaris-induced histamine release from isolated rat peritoneal mast cells
Rat peritoneal mast cells were harvested from the abdominal cavities of the rats following the method described in a previous report by Amellal et al. (Amellal et al., 1985) . The abdominal region was gently massaged for 90 s, and peritoneal fluid was collected and centrifuged for 1 min at 280 × g at 4°C. After centrifugation, the precipitant was mixed in 20% Ficoll, and the mixture was loaded onto layers of 40% and 30% Ficoll, and then centrifuged for 20 min at 350 × g. The layer containing the mast cell pellet was then pooled and washed twice in phosphate buffered saline (PBS) solution. Next, 0.01 µg/50 µl of fractions A1-A4, 0.1 µg/50 µl of A4-1-A4-4, and 1.0 µg/50 µl of eMMBP or caffeic acid dissolved in PBS were added to mast cells (1 × 10 5 cells/0.2 ml) and the mixture was preincubated at 37°C for 10 min before the reaction. Compound 48/80 (0.2 µg/0.05 ml) was added to the tubes and the mixture was incubated at 37°C for 10 min. In the control, only PBS was added to mast cells (1 × 10 5 cells/0.2 ml) and the mixture was preincubated at 37°C for 10 min before the reaction. Compound 48/80 (0.2 µg/ 0.05 ml) was added and the mixture was incubated. The reaction was stopped by the addition of cool PBS (0.3 ml) to the tubes. The tubes were centrifuged for 1 min at 280 × g, and the histamine content in the supernatant was measured by enzyme-linked immunosorbent assay (ELISA; SPI Bio, Paris, France). Histamine from mast cells treated with A4-1-A4-4 (0.01, 0.1 and 1.0 µg/50 µl) that were isolated from A4 were measured in the same way. Inhibition by each fraction or ketotifen was expressed as the percentage of histamine release compared with the total histamine in the mast cells before the reaction.
Histamine-induced contraction of the isolated guinea pig ileum
The guinea pigs were anesthetized with diethyl ether, then euthanized by decapitation. The ileum was rapidly removed and immersed in ice-cold, oxygenated, modified Krebs-Henseleit solution (KHS) consisting of 118.0 mM NaCl, 4.7 mM KCl, 25.0 mM NaHCO3, 1.8 mM CaCl2, 1.2 mM NaH2PO4, 1.2 mM MgSO4 and 11.0 mM dextrose. The ileal segments (intact ileum), approximately 1.0 cm in length, were placed longitudinally in a well-oxygenated (95% O2, 5% CO2) bath containing 10 ml of KHS at 30°C. The segments were equilibrated for 60 min before the experiments were initiated. Changes in the tone of the preparation with a 1.0-g initial resting tension were measured with an isometric transducer (TB-611T; Nihon Kohden, Tokyo, Japan). For the contraction studies, the ileal segments were first contracted using 80 mM K + , these responses being taken as 100%. After washing and equilibrating for 1 h, the segments were treated with A1 (500 µg/ml), A2 (500 µg/ml), A3 (500 µg/ml), A4 (500 µg/ml), A5 (500 µg/ml), ketotifen (0.05, 0.5, 5 ng/ml), caffeic acid (200, 500 µg/ml), rutin (200, 500 µg/ml) or vehicle for 30 min. After this incubation period, histamine (10 -9 -10 -4.5 M) was cumulatively applied. Contractile responses were expressed as a percentage of the contraction previously induced by 80 mM KCl.
Statistical analysis
For the experiments concerning histamine release from mast cells, the data are expressed as mean ± SD of the number of animals described in the figure legends. The data were analyzed using one-way analysis of variance (ANOVA), followed by Dunnett's test using StatView software. P values of less than 0.05 were considered significant. For the experiments concerning histamine-induced contraction, statistical comparisons between concentration-response curves were made using two-way ANOVA, with Bonferroni's correction for multiple comparisons performed post hoc. P<0.05 was considered significant.
Results and Discussion
eMMBP was separated into fractions A1-A5 by extraction using various concentrations of MeOH (less than 20%, 30%, 40%, 50% and 100% ) following the protocol described in our previous report (Kusano et al., 2003) (Fig. 1) . Charts of eMMBP and fractions A1-A4 identified by HPLC are shown in Figs. 2 and 3, respectively. Peaks 1-6 were identified as caffeic acid, 3,4-di-Ocaffeoylquinic acid, 3,5-di-O-caffeoylquinic acid, rutin, hyperin and isoquercitrin, respectively, by HPLC with their standards, which were isolated, purified from eMMBP, and their structure was analyzed by nuclear magnetic resonance (NMR) (Kusano et al., 2003) . It was revealed that caffeic acid was the major component of fractions A1-A3 of eMMBP, and that flavonoids were the main components of fractions A4 and A5. The effects of fractions A1-A5 (0.1 µg/50 µl) on histamine release from mast cells were compared (Table 1) . A4 (elution with 50% MeOH) inhibited histamine release from mast cells most significantly. Fraction A4 was subdivided into fractions A4-1-A4-4, as shown in Figs. 4a-d. The effects of fractions A4-1-A4-4, caffeic acid and eMMBP at doses of 0.01 µg/50 µl, 0.1 µg/50 µl and 1.0 µg/50 µl, respectively, on histamine release from mast cells were compared ( Table 2) . The inhibitory activities of the histamine release were observed in the following orders: A4 > A1 > A2 > A5 > A3 and A4-1 > A4-2 > A4-3 > A4-4. Caffeoylquinic acid, hyperin and isoquercitrin were included in fractions A4 and A4-1, hyperin and isoquercitrin were included in fractions A5 and A4-2, rutin and small amounts of hyperin and isoquercitrin were included in fraction A4-3, and a small amount of rutin was included in fraction A4-4. These results suggest that A4 and A4-1 mainly contained caffeoylquinic acid, hyperin and isoquercitrin, which participate in the inhibition of histamine release. These results are also supported by previous reports (Amellal et al., 1985; Inoue et al., 2002) . Amellal et al. (Amellal et al., 1985) report that the catechol structure in the B ring and the C2-C3 double bond in the C ring of flavonoids are essential for the inhibition of histamine release. Hyperin and isoquercitrin have the catechol structure in the B ring and the C2-C3 double bond in the C ring. It has been reported that Houttuynia cordata containing hyperin and isoquercitrin has anti-allergic activity and inhibits histamine release (Li et al., 2005) . Yamamoto et al. (2004) report that rutin in tomato skin slightly inhibits histamine release from mast cells, however, quercetin that was an agricon of rutin inhibited histamine release (Kaku et al., 2000) . In the present study, the inhibition of histamine release from the mast cells of fraction contained mainly rutin was not strong, suggesting that contained mainly hyperin and isoquercitrin of per unit weight inhibit histamine release more effectively. The inhibitory activity of eMMBP with much caffeic acid was more effective than that of fraction A4-1-A4-2 with little caffeic acid, however, the inhibitory activity of fraction A4-1-A4-3 was significantly effective. eMMBP contains a significant amount of caffeic acid, and the inhibition of histamine release from mast cells by eMMBP depends on the presence of caffeic acid, caffeoylquinic acid, hyperin, isoquercitrin, and rutin. Hossen et al. (2006) report that caffeic acid dose-dependently inhibits Compound 48/80-induced allergic symptoms in mice. In the Fig. 2 . HPLC chromatograms of eMMBP. Peak 1, caffeic acid; peak 2, 3,4-di-O-caffeoylquinic acid; peak 3, 3,5-di-O-caffeoylquinic acid; peak 5, hyperin; peak 6, isoquercitrin. The chromatographic conditions are described in the Methods section. Fig. 3 . HPLC chromatograms of fractions A1-A5 in eMMBP. Peak 1, caffeic acid; peak 2, 3,4-di-O-caffeoylquinic acid; peak 3, 3,5-di-O-caffeoylquinic acid; peak 4, rutin; peak 5, hyperin; peak 6, isoquercitrin. The chromatographic conditions are described in the Methods section. 3.6 ± 3.3*** 95.3
Each sample was added to the mast cells (1 × 10 5 cells/0.2 ml) in a tube. Each value (%) represents the mean ± SD of 5 experiments (5 rats were used). *, P<0.05; **, P<0.01, ***, P<0.001, significantly different from controls. The data were analyzed by two-way ANOVA, followed by Bonferroni's test. 46.5 ± 9.5** 38.4
(1.0 µg/50 µl)
37.6 ± 6.8*** 50.1
Each sample was added to the mast cells (1 × 10 5 cells/0.2 ml) in a tube. Each value (%) represents the mean ± SD of 5 experiments (5 rats were used). *, P<0.05; **, P<0.01; ***, P<0.001, significantly different from controls. The data were analyzed by two-way ANOVA, followed by Bonferroni's test. present study, large amounts (1,000 µg/ml) of caffeic acid inhibited histamine release from mast cells, and high doses of caffeic acid were found to inhibit histamine release from mast cells dose-dependently (Table 2) .
Histamine is an important chemical mediator in allergic reactions and inflammation. In the present study, we identified an antihistaminic action of MMBP on H1-receptor because histamine-induced contraction was dose-dependently suppressed by ketotifen, an H1-receptor antagonist treatment (Fig. 5) . The effects of fractions A1-A5 of eMMBP on the histamineinduced contraction in the isolated guinea pig ileum are shown in Fig. 6 . As compared with vehicle treatment, the histamine-induced contraction of the isolated guinea pig ileum was largely inhibited by fraction A5 (Fig. 6) . On the other hand, fraction A2 slightly but significantly inhibited the histamine-induced contraction. Moreover, we investigated the effect of caffeic acid (component of fraction A2) or rutin (component of fraction A5) on the histamine-induced contraction in guinea pig ileum (Fig. 7) . Although the histamine-induced contraction was not affected by caffeic acid, such contraction was significantly inhibited by rutin (Fig. 7) . These results suggest that the antihistaminic activity of fraction A5 may partly contribute to an effect of rutin. Although other component(s) of fraction A5 can produce the antihistaminic activity remains unclear, further studies will be required on this point.
It was previously reported that extracts from Droserae Herba, which contain the flavonoids quercetin and isoquercitrin, have antihistaminic activity (Melzig et al., 2001) ; however, to the best of our knowledge, there have been no reports of antihistaminic activity associated with caffeic acid, caffeoylquinic acid, quercetin or rutin. Antagonistic effects are often reported for synthetic drugs (Abe et al., 1994; Kobayashi et al., 1998; Takizawa et al., 2001; Fukuda et al., 2003) , however, there are few reports on natural products such as herbaceous plants (Melzig et al., 2001) . In the present study, it was shown that a fraction contained mixture of hyperin, : vehicle (n=15); : ketotifen (0.05 ng/ml; n=4); : ketotifen (0.5 ng/ml; n=6); : ketotifen (5 ng/ml; n=6). ***, P<0. 001, vs. vehicletreated group. isoquercitrin and rutin functioned as an antagonist of H1-receptor. To the best of our knowledge, there has been no previous report of H1-receptor antagonizing activity by a natural constituent of a food or plant. The present results indicate that rutin is a strong antagonist of H1- (500 µg/ml; n=7); : A2 (500 µg/ml; n=6); : A3 (500 µg/ml; n=7); : A4 (500 µg/ml; n=8); : A5 (500 µg/ml; n=6). *, P<0.05, ***, P<0. 001, vs. vehicle-treated group. receptor, and that caffeic acid has no antihistaminic activity, though it does inhibit histamine release. Our results suggest that the main components involved in antagonizing H1-receptor are different from those involved in the inhibition of histamine release from mast cells.
In conclusion, the anti-allergic action of eMMBP is based on antagonists of H1-receptor and the inhibition of histamine release. The H1-receptor signaling may be inhibited by fraction contained flavonoids such as hyperin, isoquercitrin and rutin in eMMBP. Moreover, fraction contained these flavonoids, caffeic acid and caffeoylquinic acid inhibit histamine release from mast cells.
